3 ms·

This is a well understood concept in medicine, and a central part of the drug approval process.

• Pyramus 5y ago
  Yes and no. Yes, obviously the drug development process is very complex and a lot of thought goes into interactions at the N=1 level. However, we are hardly at the point where drugs are developed for individuals, based on their genetic makeup. The best we can do (with exceptions) is design drugs for women/men, and this is a very recent development. In addition, per definition, a drug can only be effective/safe at the population level. To make a very simple example, we think caffeine sensitivity has two distinct high/low genotypes. As a result, all recommendations of caffeine consumption will either be too high or too low.
• AnthonBerg 5y ago
  It can be witnessed as a central part of the drug approval process, certainly. However, sometimes the lack of this perspective can also be noticed during the interpretation of scientific results. The perspective is not consistently part of the discourse.